Serum miRNA Signature in Rheumatoid Arthritis and “At-Risk Individuals”

BackgroundMicroRNAs (miRNAs) are small non-coding RNAs which have been implicated as potential biomarkers or therapeutic targets in autoimmune diseases. This study examines circulatory miRNAs in RA patients and further investigates if a serum miRNA signature precedes clinical manifestations of disea...

Full description

Bibliographic Details
Main Authors: Clare C. Cunningham, Sarah Wade, Achilleas Floudas, Carl Orr, Trudy McGarry, Siobhan Wade, Sian Cregan, Ursula Fearon, Douglas J. Veale
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.633201/full
id doaj-97005a631c7646aa88935067eb0b04a6
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Clare C. Cunningham
Clare C. Cunningham
Sarah Wade
Sarah Wade
Achilleas Floudas
Achilleas Floudas
Carl Orr
Trudy McGarry
Trudy McGarry
Siobhan Wade
Siobhan Wade
Sian Cregan
Ursula Fearon
Ursula Fearon
Douglas J. Veale
spellingShingle Clare C. Cunningham
Clare C. Cunningham
Sarah Wade
Sarah Wade
Achilleas Floudas
Achilleas Floudas
Carl Orr
Trudy McGarry
Trudy McGarry
Siobhan Wade
Siobhan Wade
Sian Cregan
Ursula Fearon
Ursula Fearon
Douglas J. Veale
Serum miRNA Signature in Rheumatoid Arthritis and “At-Risk Individuals”
Frontiers in Immunology
rheumatoid arthritis
microRNA
inflammation
arthralgia
therapy
at-risk individuals
author_facet Clare C. Cunningham
Clare C. Cunningham
Sarah Wade
Sarah Wade
Achilleas Floudas
Achilleas Floudas
Carl Orr
Trudy McGarry
Trudy McGarry
Siobhan Wade
Siobhan Wade
Sian Cregan
Ursula Fearon
Ursula Fearon
Douglas J. Veale
author_sort Clare C. Cunningham
title Serum miRNA Signature in Rheumatoid Arthritis and “At-Risk Individuals”
title_short Serum miRNA Signature in Rheumatoid Arthritis and “At-Risk Individuals”
title_full Serum miRNA Signature in Rheumatoid Arthritis and “At-Risk Individuals”
title_fullStr Serum miRNA Signature in Rheumatoid Arthritis and “At-Risk Individuals”
title_full_unstemmed Serum miRNA Signature in Rheumatoid Arthritis and “At-Risk Individuals”
title_sort serum mirna signature in rheumatoid arthritis and “at-risk individuals”
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2021-03-01
description BackgroundMicroRNAs (miRNAs) are small non-coding RNAs which have been implicated as potential biomarkers or therapeutic targets in autoimmune diseases. This study examines circulatory miRNAs in RA patients and further investigates if a serum miRNA signature precedes clinical manifestations of disease in arthralgia or “at-risk individuals”.MethodsSerum was collected from HC subjects (N = 20), RA patients (N = 50), and arthralgia subjects (N = 10), in addition to a subgroup of the RA patients post-methotrexate (MTX) (N = 18). The FirePlex miRNA Immunology-V2 panel was selected for multiplex analysis of 68 miRNAs in each sample. DNA intelligent analysis (DIANA)-mirPath and Ingenuity Pathway Analysis (IPA) software were used to predict pathways targeted by the dysregulated miRNAs.Results8 miRNA (miR-126-3p, let-7d-5p, miR-431-3p, miR-221-3p, miR-24-3p, miR-130a-3p, miR-339-5p, let-7i-5p) were significantly elevated in RA serum compared to HC (all p < 0.01) and 1 miRNA (miR-17-5p) was significantly lower in RA (p < 0.01). High specificity and sensitivity were determined by receiver operating characteristic (ROC) curve analysis. Both miR-339-5p and let-7i-5p were significantly reduced post-MTX (both p < 0.01). MiR-126-3p, let-7d-5p, miR-431-3p, miR-221-3p, miR-24-3p, miR-130a-3p were also significantly elevated in subjects “at risk” of developing RA (all p < 0.05) compared to HC. IPA analysis of this miRNA signature identified downstream targets including key transcription factors NF-κB, STAT-1, STAT-3, cytokines IL-1β, TNF-α, and matrix-metalloproteases all importantly associated with RA pathogenesis.ConclusionThis study identified six miRNAs that are altered in both RA and “at-risk individuals,” which potentially regulate key downstream pathways involved in regulating inflammation. These may have potential as predictive signature for disease onset and early progression.
topic rheumatoid arthritis
microRNA
inflammation
arthralgia
therapy
at-risk individuals
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.633201/full
work_keys_str_mv AT clareccunningham serummirnasignatureinrheumatoidarthritisandatriskindividuals
AT clareccunningham serummirnasignatureinrheumatoidarthritisandatriskindividuals
AT sarahwade serummirnasignatureinrheumatoidarthritisandatriskindividuals
AT sarahwade serummirnasignatureinrheumatoidarthritisandatriskindividuals
AT achilleasfloudas serummirnasignatureinrheumatoidarthritisandatriskindividuals
AT achilleasfloudas serummirnasignatureinrheumatoidarthritisandatriskindividuals
AT carlorr serummirnasignatureinrheumatoidarthritisandatriskindividuals
AT trudymcgarry serummirnasignatureinrheumatoidarthritisandatriskindividuals
AT trudymcgarry serummirnasignatureinrheumatoidarthritisandatriskindividuals
AT siobhanwade serummirnasignatureinrheumatoidarthritisandatriskindividuals
AT siobhanwade serummirnasignatureinrheumatoidarthritisandatriskindividuals
AT siancregan serummirnasignatureinrheumatoidarthritisandatriskindividuals
AT ursulafearon serummirnasignatureinrheumatoidarthritisandatriskindividuals
AT ursulafearon serummirnasignatureinrheumatoidarthritisandatriskindividuals
AT douglasjveale serummirnasignatureinrheumatoidarthritisandatriskindividuals
_version_ 1724233236969684992
spelling doaj-97005a631c7646aa88935067eb0b04a62021-03-03T05:59:02ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-03-011210.3389/fimmu.2021.633201633201Serum miRNA Signature in Rheumatoid Arthritis and “At-Risk Individuals”Clare C. Cunningham0Clare C. Cunningham1Sarah Wade2Sarah Wade3Achilleas Floudas4Achilleas Floudas5Carl Orr6Trudy McGarry7Trudy McGarry8Siobhan Wade9Siobhan Wade10Sian Cregan11Ursula Fearon12Ursula Fearon13Douglas J. Veale14Molecular Rheumatology, School of Medicine, Trinity College Dublin, Dublin, IrelandEUropean League Against Rheumatism (EULAR) Centre of Excellence, Centre for Arthritis & Rheumatic Diseases, University College Dublin, Dublin, IrelandMolecular Rheumatology, School of Medicine, Trinity College Dublin, Dublin, IrelandEUropean League Against Rheumatism (EULAR) Centre of Excellence, Centre for Arthritis & Rheumatic Diseases, University College Dublin, Dublin, IrelandMolecular Rheumatology, School of Medicine, Trinity College Dublin, Dublin, IrelandEUropean League Against Rheumatism (EULAR) Centre of Excellence, Centre for Arthritis & Rheumatic Diseases, University College Dublin, Dublin, IrelandEUropean League Against Rheumatism (EULAR) Centre of Excellence, Centre for Arthritis & Rheumatic Diseases, University College Dublin, Dublin, IrelandMolecular Rheumatology, School of Medicine, Trinity College Dublin, Dublin, IrelandEUropean League Against Rheumatism (EULAR) Centre of Excellence, Centre for Arthritis & Rheumatic Diseases, University College Dublin, Dublin, IrelandMolecular Rheumatology, School of Medicine, Trinity College Dublin, Dublin, IrelandEUropean League Against Rheumatism (EULAR) Centre of Excellence, Centre for Arthritis & Rheumatic Diseases, University College Dublin, Dublin, IrelandEUropean League Against Rheumatism (EULAR) Centre of Excellence, Centre for Arthritis & Rheumatic Diseases, University College Dublin, Dublin, IrelandMolecular Rheumatology, School of Medicine, Trinity College Dublin, Dublin, IrelandEUropean League Against Rheumatism (EULAR) Centre of Excellence, Centre for Arthritis & Rheumatic Diseases, University College Dublin, Dublin, IrelandEUropean League Against Rheumatism (EULAR) Centre of Excellence, Centre for Arthritis & Rheumatic Diseases, University College Dublin, Dublin, IrelandBackgroundMicroRNAs (miRNAs) are small non-coding RNAs which have been implicated as potential biomarkers or therapeutic targets in autoimmune diseases. This study examines circulatory miRNAs in RA patients and further investigates if a serum miRNA signature precedes clinical manifestations of disease in arthralgia or “at-risk individuals”.MethodsSerum was collected from HC subjects (N = 20), RA patients (N = 50), and arthralgia subjects (N = 10), in addition to a subgroup of the RA patients post-methotrexate (MTX) (N = 18). The FirePlex miRNA Immunology-V2 panel was selected for multiplex analysis of 68 miRNAs in each sample. DNA intelligent analysis (DIANA)-mirPath and Ingenuity Pathway Analysis (IPA) software were used to predict pathways targeted by the dysregulated miRNAs.Results8 miRNA (miR-126-3p, let-7d-5p, miR-431-3p, miR-221-3p, miR-24-3p, miR-130a-3p, miR-339-5p, let-7i-5p) were significantly elevated in RA serum compared to HC (all p < 0.01) and 1 miRNA (miR-17-5p) was significantly lower in RA (p < 0.01). High specificity and sensitivity were determined by receiver operating characteristic (ROC) curve analysis. Both miR-339-5p and let-7i-5p were significantly reduced post-MTX (both p < 0.01). MiR-126-3p, let-7d-5p, miR-431-3p, miR-221-3p, miR-24-3p, miR-130a-3p were also significantly elevated in subjects “at risk” of developing RA (all p < 0.05) compared to HC. IPA analysis of this miRNA signature identified downstream targets including key transcription factors NF-κB, STAT-1, STAT-3, cytokines IL-1β, TNF-α, and matrix-metalloproteases all importantly associated with RA pathogenesis.ConclusionThis study identified six miRNAs that are altered in both RA and “at-risk individuals,” which potentially regulate key downstream pathways involved in regulating inflammation. These may have potential as predictive signature for disease onset and early progression.https://www.frontiersin.org/articles/10.3389/fimmu.2021.633201/fullrheumatoid arthritismicroRNAinflammationarthralgiatherapyat-risk individuals